Thousands of men in England who have prostate cancer will be offered high-powered precision radiotherapy that will slash the number of treatment sessions they typically need from 20 to just five.
Johnson & Johnson (J&J) has announced results from the final analysis of the phase 3 PROTEUS study showing that Erleada (apalutamide) plus hormone therapy (androgen deprivation therapy) significantly ...
Reduction in prostate cancer-specific mortality corresponds to two fewer deaths per 1,000/ (HealthDay News) — Prostate-specific antigen (PSA) screening likely results in a reduction in prostate cancer ...
Non-cancer causes of death in patients with hormone-sensitive prostate cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium. This abstract does not include a ...
Researchers have detected microplastics in nearly all prostate cancer tumors examined in a new study. Tumor tissue contained about 2.5 times more plastic than nearby healthy prostate tissue.
For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has emerged over the past two decades. The prostate is a small gland that sits ...
Hosted on MSN
Stage 4 prostate cancer cases increased after reduction in PSA screening, research suggests
New research suggests that cases of stage 4 prostate cancer have gone up since Canada changed guidelines for a screening blood test, known as PSA, but experts disagree about whether screening ...
MIAMI, FLORIDA / ACCESS Newswire / November 25, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) (“Telomir” or the “Company”), a preclinical-stage biotechnology company developing therapies that ...
Prostate cancer tests in the UK will only be offered to men with a specific cancer gene variant in a controversial decision that will put pressure on the government to overrule the advice. Targeted ...
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results